Skip to main content
. Author manuscript; available in PMC: 2019 Apr 4.
Published in final edited form as: Sci Transl Med. 2018 Apr 4;10(435):eaai7786. doi: 10.1126/scitranslmed.aai7786

Table 2. Rifampin and rifapentine penetration into rabbit tubercular lesions and healthy lung tissue.

n, number of samples; N, number of animals. FIX, parameter was fixed; 1/hour, per hour; CL, clearance; V, volume of distribution; CV, coefficient of variance.

Rifampin (sample size) n/N Rifapentine (sample size) n/N
Plasma 38/8 49/11
CL (liter/hour per kg) 0.175 (3) 0.087 (26)
V (liter/kg) 0.54 (5) 0.67 (11)
Residual error of plasma, CV % 34 (5) 23 (15)
IIV (CL), CV % 42 (17) 65 (30)
IIV (V), CV % 30 (42)
Correlation CL-V 0.59 (27)
Uninvolved lung 15/5 42/11
Ratio of uninvolved lung/plasma 0.78 (12) 0.71 (12)
Rate constant of plasma to uninvolved lung (1/hour) 1.29 (27) 10 FIX
Residual variability of uninvolved lung, CV % 22 (41) 33 (38)
Cellular lesion 20/5 19/6
Ratio of cellular lesion/plasma 1.12 (5) 1.1 (14)
Rate constant of plasma to cellular lesion (1/hour) 0.59 (19) 1.86 (33)
Residual variability of cellular lesion, CV % 19 (30) 27 (25)
Tissue surrounding lesion 12/5 15/6
Ratio of tissue surrounding lesion/plasma 1.01 (16) 1.05
Rate constant of plasma to tissue surrounding lesion (1/hour) 0.74 (138) 0.83
Residual variability of tissue surrounding lesion, CV % 22 (55) 29
Cavity caseum 9/3 13/4
Ratio of cavity caseum/plasma 1.11 (21) 0.25 (21)
Rate constant of plasma to cavity caseum (1/hour) 0.086 (40) 234 (40)
Residual variability of cavity caseum, CV % 57 (5) 60 (31)
Cavity wall 7/2 16/4
Ratio of cavity wall/plasma 0.98 (8) 1.01 (8)
Rate constant of plasma to cavity wall (1/hour) 0.37 (13) 0.63 (4)
Residual variability of cavity wall, CV % 26 (42) 15 (5)